| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9340924 | Urologic Oncology: Seminars and Original Investigations | 2005 | 5 Pages |
Abstract
Minimal antitumor activity of single-agent oxaliplatin was observed in TCC patients previously treated with chemotherapy regardless of time from prior cisplatin exposure.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Eric M.D., M.Sc., Everett M.D., Malcolm J. M.D., L. Philip M.A., Kristin Hoving, Walter M. M.D.,